Jun 14, 2017 20:03 pm UTC| Business
Las Vegas, NV, June 14, 2017 -- Sunrise Hospital and Medical Center announces today it has been accredited by The Joint Commission as an Advanced Comprehensive Stroke Center, becoming the first medical center in Nevada...
Monroe Capital Corporation Completes Public Offering of Common Shares
Jun 14, 2017 20:03 pm UTC| Business
CHICAGO, June 14, 2017 -- Monroe Capital Corporation (the “Company”) (NASDAQ:MRCC) announced today the completion of an upsized underwritten public offering of 3,450,000 shares of its common stock (including 450,000...
Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock
Jun 14, 2017 20:01 pm UTC| Business
MENLO PARK, Calif., June 14, 2017 -- Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Pacific...
Jun 14, 2017 20:01 pm UTC| Business
NEW YORK, June 14, 2017 -- New York Mortgage Trust, Inc. (Nasdaq:NYMT) (the “Company”) announced today that its Board of Directors declared a regular quarterly cash dividend of $0.20 per share on shares of its common...
Zosano Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Jun 14, 2017 20:01 pm UTC| Business
FREMONT, Calif., June 14, 2017 -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical stage biopharmaceutical company focused on providing rapid systemic administration of therapeutics to patients using our proprietary...
Adesto Technologies Corporation Announces Proposed Public Offering of Common Stock
Jun 14, 2017 20:00 pm UTC| Business
SANTA CLARA, Calif., June 14, 2017 -- Adesto Technologies Corporation (NASDAQ:IOTS), a leading provider of application-specific, feature-rich, ultra-low power non-volatile memory products, today announced that it...
AveXis Announces Alignment with FDA on GMP Commercial Manufacturing Process for AVXS-101
Jun 14, 2017 20:00 pm UTC| Business
– Agency is supportive of proposed analytical methods and comparability protocol – – AveXis anticipates initiating U.S. SMA Type 1 and Type 2 trials in Q3 2017 with product from new process – – AveXis manufacturing...